1110sek
-5,1 %
Date:2025-06-13Time:18:00:00Latest report:Q1-2025List:First NorthTicker:FLUI
Market Cap:15 msekEnterprise Value:6 msekNet Sales:1,77 msekEarnings:-10,3 msekEmployees:0ISIN:SE0023595459

Ratios

10-year key figure history for Fluicell turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Fluicell with index and moving average MA50 and MA200.

Stockprice:11,10
MA50:11,78
MA200:18,51
Price/MA200:-40,0 %
RSI (14):47,4
Price/MA50:-5,8 %

Description

Fluicell is a biotechnology company. The company conducts research and development in processing the composition of cells in the development of new pharmaceuticals. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and finally process cells. In addition, there is expertise in 2D / 3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.

Biotechnology